- Walgreens partners with United Nations Foundation's Shot@Life campaign
- Study: Cough-cold manufacturers' voluntary label change on pediatric products reduced ER admissions
- FDA advisory committee to consider OTC NDA for asthma-relieving Primatene HFA
- Study: 2,000 IUs of vitamin E daily effective in slowing functional decline in AD patients
- PhRMA report lists 271 vaccines in development
ALLENTOWN, Pa. — Medical device maker PMD Healthcare has launched what it calls the first personal spirometer to monitor lung function, the company said.
PMD, based in Allentown, Pa., announced the launch of the Spiro PD, which recently received approval from the Food and Drug Administration. The device is designed to enable patients with such lung diseases as asthma, chronic obstructive pulmonary disease, cystic fibrosis and lung transplants "easily and accurately" monitor lung function anytime and anywhere.
"With the increase in prevalence of emergency room visits and hospitalizations for asthma and other pulmonary problems in the U.S., the availability of Spiro PD is especially significant," World Allergy Organization board member and University of Tennessee Health Sciences Center clinical professor Michael Blaiss said. "This new device allows patients and parents of young children with lung disease to know exactly how their condition is doing at any time, enabling patients to have a more active role in controlling their lung health and potentially identifying problems before the need for costly emergency treatment."